NEW YORK, April 7, 2017 /PRNewswire/ --
Stock-Callers.com directs investors' attention to the Health Care Plans industry,which includes companies that offer health benefit plans to employers and individuals who require long-term care or specialty benefits, along with point-of-service plans, traditional indemnity plans, and other hybrid plans. Equities in today's lineup
On Thursday, shares in Woonsocket, Rhode Island headquartered CVS Health Corp. saw a slight drop of 0.03%, ending the day at $77.01 with a total trading volume of 6.33 million shares. The stock is trading below its 50-day moving average by 2.57%. Shares of the Company, which together with its subsidiaries, provides integrated pharmacy health care services, have a Relative Strength Index (RSI) of 30.79.
On April 05th, 2017, CVS Health announced that it was recognized by Billion Dollar Roundtable, a top-level corporate advocacy organization that promotes supply-chain diversity excellence, for reaching its goal of spending over $1 billion with diverse suppliers. CVS Health joins the ranks as one of 26 major US-based corporations that provide thought leadership and solutions-driven exploration of key issues in supplier diversity. CVS complete research report is just a click away and free at:
Shares in Saint Louis, Missouri headquartered Express Scripts Holding Co. ended the day 0.42% lower at $65.79. A total volume of 4.97 million shares was traded, which was above their three months average volume of 4.39 million shares. The stock is trading below its 50-day moving average by 2.96%. Furthermore, shares of Express Scripts, which operates as a pharmacy benefit management company in the US, Canada, and Europe, have an RSI of 47.24.
On March 15th, 2017, research firm Wells Fargo downgraded the Company's stock rating from 'Market Perform' to 'Underperform'.
On April 04th, 2017, Express Scripts announced that it lowered prescription drug spending for workers' compensation payers by 7.6% in 2016, according to the 11th edition of the Company's Workers' Compensation Drug Trend Report. The complimentary report on ESRX can be downloaded at:
At the close of trading on Thursday, shares in Minnetonka, Minnesota-based UnitedHealth Group Inc. finished 0.02% lower at $165.34 with a total trading volume of 2.92 million shares. The stock has advanced 2.33% over the previous three months and 3.70% on an YTD basis. The Company's shares are trading above their 50-day and 200-day moving averages by 0.58% and 10.46%, respectively. Additionally, shares of UnitedHealth, which operates as a diversified health and well-being company in the US, have an RSI of 49.46.
On March 22nd, 2017, UnitedHealth announced that the Company will release its Q1 2017 financial results on Tuesday, April 18th, 2017, before the market opens. The Company will also host a teleconference at 8:45 a.m. ET on the same day to discuss the results with analysts and investors. The call will be webcast on the Investors page of the Company's website.
On April 05th, 2017, research firm Deutsche Bank initiated a 'Buy' rating on the Company's stock, with a target price of $183 per share. Sign up for your complimentary research report on UNH at:
Hartford, Connecticut-based Aetna Inc.'s shares recorded a trading volume of 2.29 million shares at the end of yesterday's session. The stock closed the day 1.23% higher at $128.84. The Company's shares have advanced 3.69% in the last three months and 4.11% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 1.68% and 6.86%, respectively. Additionally, shares of Aetna, which operates as a health care benefits company in the US, have an RSI of 53.97.
On April 05th, 2017, research firm Deutsche Bank initiated a 'Hold' rating on the Company's stock, with a target price of $135 per share. Get free access to your research report on AET at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!